We are live on ! Find out more
Squarepoint

Squarepoint Portfolio holdings

AUM $90.8B Turnover 33.11%
1-Year Est. Return 26.98%
 

Squarepoint runs funds that use computer models to trade many kinds of assets around the world. It began as nQuant, a trading unit set up inside Lehman Brothers in 2000 by its founders, Olivier Durantel and Gregoire Schneider. Barclays took over nQuant in 2008, and in December 2014 it was spun off as an independent firm and renamed Squarepoint. In 2022 Squarepoint formed STG, a separate trading group that shares much of its infrastructure but has its own investment staff, and in 2021 it partnered with Arini Capital, a European hedge fund.

This Fund
S&P 500
This Quarter Est. Return
+4.02%
1 Year Est. Return
+26.98%
3 Year Est. Return
+88.41%
5 Year Est. Return
+62.11%
10 Year Est. Return
+188.73%
AUM
$7.55B
AUM Growth
+$1.25B
Cap. Flow
+$1.17B
Cap. Flow %
15.56%
Top 10 Hldgs %
9.43%
Holding
2,269
New
635
Increased
628
Reduced
448
Closed
556
Avg Time Held Equity + Options
0.5 years
Top 10 Avg Time Held Equity + Options
0 years
Top 20 Avg Time Held Equity + Options
0.1 years
Avg Time Held Equity only
0.5 years
Top 10 Avg Time Held Equity only
0 years
Top 20 Avg Time Held Equity only
0.1 years

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 17%
2 Financials 13.53%
3 Healthcare 13.33%
4 Technology 13.18%
5 Industrials 11.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
KLDX
1301
DELISTED
Klondex Mines
KLDX
$369K ﹤0.01%
159,574
-192,157
-55% -$468K
2017 Q4
2 quarters
VYGR icon
1302
Voyager Therapeutics
VYGR
$100M
$367K ﹤0.01%
+18,800
New +$372K
2018 Q2
0 quarters
TTD icon
1303
Trade Desk
TTD
$6.89B
$366K ﹤0.01%
39,000
-29,570
-43% -$208K
2017 Q4
2 quarters
MNTA
1304
DELISTED
Momenta Pharmaceuticals
MNTA
$366K ﹤0.01%
17,879
-40,251
-69% -$864K
2017 Q2
4 quarters
EVBG icon
1305
DELISTED
Everbridge
EVBG
$365K ﹤0.01%
7,700
+699
+10% +$29.7K
2017 Q4
2 quarters
REV
1306
DELISTED
Revlon
REV
$365K ﹤0.01%
+20,784
New +$410K
2018 Q2
0 quarters
SPNT icon
1307
SiriusPoint
SPNT
$3.02B
$364K ﹤0.01%
29,124
+16,707
+135% +$223K
2018 Q1
1 quarter
MODV icon
1308
DELISTED
ModivCare
MODV
$363K ﹤0.01%
+4,624
New +$347K
2018 Q2
0 quarters
PBH icon
1309
Prestige Consumer Healthcare
PBH
$2.35B
$363K ﹤0.01%
9,471
-33,100
-78% -$1.12M
2017 Q2
4 quarters
LCI
1310
DELISTED
Lannett
LCI
$361K ﹤0.01%
6,639
+1,950
+42% +$123K
2017 Q2
4 quarters
CBLK
1311
DELISTED
Carbon Black
CBLK
$361K ﹤0.01%
+13,885
New +$358K
2018 Q2
0 quarters
MERC icon
1312
Mercer International
MERC
$12.1M
$358K ﹤0.01%
20,433
+4,933
+32% +$74.2K
2017 Q4
2 quarters
SPWR icon
1313
DELISTED
SunPower
SPWR
$358K ﹤0.01%
71,271
+23,934
+51% +$131K
2016 Q4
6 quarters
CPAY icon
1314
Corpay
CPAY
$27.8B
$357K ﹤0.01%
1,697
-40,794
-96% -$8.37M
2018 Q1
1 quarter
CIO
1315
DELISTED
City Office REIT
CIO
$355K ﹤0.01%
+27,666
New +$329K
2018 Q2
0 quarters
PACW
1316
DELISTED
PacWest Bancorp
PACW
$355K ﹤0.01%
7,179
-939
-12% -$49.1K
2017 Q4
2 quarters
DIOD icon
1317
Diodes
DIOD
$3.73B
$354K ﹤0.01%
+10,284
New +$338K
2018 Q2
0 quarters
CLB icon
1318
Core Laboratories
CLB
$385M
$353K ﹤0.01%
2,800
-8,068
-74% -$982K
2017 Q4
2 quarters
NOMD icon
1319
Nomad Foods
NOMD
$1.59B
$353K ﹤0.01%
+18,413
New +$319K
2018 Q2
0 quarters
ODP icon
1320
DELISTED
ODP
ODP
$353K ﹤0.01%
13,845
-1,302
-9% -$31.7K
2017 Q4
2 quarters
GNRC icon
1321
Generac Holdings
GNRC
$12.1B
$352K ﹤0.01%
6,800
-3,254
-32% -$158K
2017 Q4
2 quarters
PCRX icon
1322
Pacira BioSciences
PCRX
$352K ﹤0.01%
+10,989
New +$379K
2018 Q2
0 quarters
SYRE icon
1323
Spyre Therapeutics
SYRE
$9.27B
$350K ﹤0.01%
1,324
+900
+212% +$221K
2018 Q1
1 quarter
CHRD icon
1324
Chord Energy
CHRD
$7.25B
$349K ﹤0.01%
26,932
-83,732
-76% -$954K
2015 Q4
10 quarters
HCI icon
1325
HCI Group
HCI
$2.35B
$348K ﹤0.01%
+8,382
New +$347K
2018 Q2
0 quarters

Similar funds

Squarepoint's Q2 2018 Portfolio in Review

As of Q2 2018, Squarepoint held 2,269 positions worth $7.55B, up 20% from $6.3B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.

Squarepoint deployed $1.17B of net new capital in Q2 2018, opening 635 new positions and adding to 628 existing holdings. Its largest new stake was Vanguard FTSE Emerging Markets ETF: 1,889,716 shares worth $79.7M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI India ETF, an estimated $47.3M trimmed.

  • Squarepoint's largest Q2 2018 buy was Vanguard FTSE Emerging Markets ETF: 1,889,716 shares worth $79.7M.
  • Squarepoint added most to iShares MSCI Taiwan ETF in Q2 2018, an estimated $102M increase.
  • Squarepoint's biggest Q2 2018 reduction was iShares MSCI India ETF, cutting an estimated $47.3M.
  • Squarepoint fully exited iShares MSCI Brazil ETF in Q2 2018, selling an estimated $119M.
  • Squarepoint's ten largest holdings make up 9.4% of its $7.55B portfolio in Q2 2018.
  • Squarepoint opened 635 new positions and closed 556 in Q2 2018.
  • Squarepoint's portfolio value rose 20% quarter-over-quarter to $7.55B.

Based on Squarepoint's 13F filing for Q2 2018, filed 14 Aug 2018.